An HR of 1.8 (95% CI, 0.7–4.5; P = 0.196) with AC/AP use was observed in the RCT‐comparator group but did not reach statistical significance, probably because of small sample size.
← all excerpts
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
1
—
—